sb 205384 has been researched along with b 43 in 2 studies
Studies (sb 205384) | Trials (sb 205384) | Recent Studies (post-2010) (sb 205384) | Studies (b 43) | Trials (b 43) | Recent Studies (post-2010) (b 43) |
---|---|---|---|---|---|
26 | 0 | 10 | 29 | 0 | 17 |
Protein | Taxonomy | sb 205384 (IC50) | b 43 (IC50) |
---|---|---|---|
Chain A, Tyrosine-protein kinase BTK | Homo sapiens (human) | 0.0007 | |
Epidermal growth factor receptor | Homo sapiens (human) | 1.6885 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.1703 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.126 | |
Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.42 | |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.315 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 2.5267 | |
Tyrosine-protein kinase CSK | Homo sapiens (human) | 5.18 | |
Angiopoietin-1 receptor | Homo sapiens (human) | 4.3433 | |
Tyrosine-protein kinase BTK | Homo sapiens (human) | 0.31 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
2 other study(ies) available for sb 205384 and b 43
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |